Gary Slatko

Gary Slatko, MD, MBA, currently serves as Chief Medical Officer at DermaSensor, Inc., overseeing the clinical development of an innovative AI/ML-powered skin cancer detection device. Previously, Gary held roles at Aquestive Therapeutics as a Clinical Development and Medical Affairs Executive, and at the FDA as Office Director for the Office of Medication Error Prevention and Risk Management. Gary's extensive experience includes leadership positions at inVentiv Health Clinical, GSK, AstraZeneca, and DuPont, focusing on risk management, drug safety, and healthcare solutions. Gary's educational background includes a Doctor of Medicine from the University of Pittsburgh, an MBA from The Johns Hopkins University, and a BA in Chemistry and Psychology from Emory University.